LONDON/COPENHAGEN (Reuters) -Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, according to a statement he posted on LinkedIn, as the obesity
Novo Nordisk Appoints Greg Miley Amid Rising Pricing Pressures
Novo Nordisk's New Leadership
LONDON/COPENHAGEN (Reuters) -Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, according to a statement he posted on LinkedIn, as the obesity drugmaker faces growing pressure from the Trump administration on drug pricing.
Background on Greg Miley
Miley, an American, is currently senior vice president of government affairs at U.S. pharmaceutical giant AbbVie. He posted the statement on LinkedIn on Friday and Novo Nordisk shared the statement with Reuters.
Challenges in the Pharmaceutical Market
(Reporting by Maggie Fick in London and Stine Jacobsen in Copenhagen, Editing by Louise Heavens)


